Cytokine production from sputum cells after allergenic challenge in IgE-mediated asthma.

PubWeight™: 1.02‹?› | Rank: Top 15%

🔗 View Article (PMID 12464042)

Published in Allergy on December 01, 2002

Authors

J Bettiol1, J Sele, M Henket, E Louis, M Malaise, P Bartsch, R Louis

Author Affiliations

1: Dpt of Pneumology and Chronic Inflammatory Disease Research Group, CHU Sart-Tilman, University of Liege, Belgium.

Articles citing this

IL-6 is required for airway mucus production induced by inhaled fungal allergens. J Immunol (2009) 1.17

Fungal allergen β-glucans trigger p38 mitogen-activated protein kinase-mediated IL-6 translation in lung epithelial cells. Am J Respir Cell Mol Biol (2011) 0.92

Cytokine production from sputum cells in eosinophilic versus non-eosinophilic asthmatics. Clin Exp Immunol (2006) 0.84

Contribution of serum IL-4 and IgE to the early prediction of horse serum allergies in guinea pigs. Asia Pac Allergy (2012) 0.80

Alveolar macrophages from allergic lungs are not committed to a pro-allergic response and can reduce airway hyperresponsiveness following ex vivo culture. Clin Exp Allergy (2008) 0.80

Differences in local versus systemic TNFalpha production in COPD: inhibitory effect of hyaluronan on LPS induced blood cell TNFalpha release. Thorax (2006) 0.80

Persistence of asthmatic response after ammonium persulfate-induced occupational asthma in mice. PLoS One (2014) 0.78

Difficult-to-control asthma management through the use of a specific protocol. Clinics (Sao Paulo) (2010) 0.78

High- and low-dose allergen challenges in asthmatic patients using inhaled corticosteroids. Br J Clin Pharmacol (2015) 0.77

Kinetics of TH2 biomarkers in sputum of asthmatics following inhaled allergen. Eur Clin Respir J (2015) 0.76

Sputum inflammatory profile before and after specific inhalation challenge in individuals with suspected occupational asthma. PLoS One (2013) 0.76

Delayed asthmatic response to allergen challenge and cytokines released by nonspecifically stimulated blood cells. ISRN Inflamm (2013) 0.75

Articles by these authors

Aligning conservation priorities across taxa in Madagascar with high-resolution planning tools. Science (2008) 5.07

Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat Genet (1996) 4.09

Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed. Ann Rheum Dis (2004) 3.64

Does co-treatment with immunosuppressors improve outcome in patients with Crohn's disease treated with adalimumab? Aliment Pharmacol Ther (2012) 2.74

Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study. Neurology (2012) 2.26

Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol (1998) 2.20

A dose adjustment in patients with rheumatoid arthritis not optimally responding to a standard dose of infliximab of 3 mg/kg every 8 weeks can be effective: a Belgian prospective study. Rheumatology (Oxford) (2005) 2.05

Therapeutic drug monitoring of azathioprine and 6-mercaptopurine metabolites in Crohn disease. Scand J Gastroenterol (2001) 1.72

Safe treatment of thiopurine S-methyltransferase deficient Crohn's disease patients with azathioprine. Gut (2003) 1.66

Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease. Aliment Pharmacol Ther (2004) 1.62

Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD study. Neurology (2010) 1.57

Lymphocytic colitis: a distinct clinical entity? A clinicopathological confrontation of lymphocytic and collagenous colitis. Gut (1999) 1.55

Biliary cholesterol hypersecretion in gallstone-susceptible mice is associated with hepatic up-regulation of the high-density lipoprotein receptor SRBI. Hepatology (2001) 1.54

Genetic markers may predict disease behavior in patients with ulcerative colitis. Gastroenterology (1997) 1.52

Association between asthma control and bronchial hyperresponsiveness and airways inflammation: a cross-sectional study in daily practice. Clin Exp Allergy (2009) 1.51

The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases. Genes Immun (2007) 1.50

Risk of Alzheimer's disease in relatives of Parkinson's disease patients with and without dementia. Neurology (1999) 1.48

Clinical and ultrasonographic predictors of joint replacement for knee osteoarthritis: results from a large, 3-year, prospective EULAR study. Ann Rheum Dis (2009) 1.47

EULAR report on the use of ultrasonography in painful knee osteoarthritis. Part 1: prevalence of inflammation in osteoarthritis. Ann Rheum Dis (2005) 1.44

Exhaled nitric oxide as a marker of asthma control in smoking patients. Eur Respir J (2009) 1.44

Effective treatment of Jo-1-associated polymyositis with T-cell-depleted autologous peripheral blood stem cell transplantation. Br J Haematol (2000) 1.41

[COPD and inflammation: statement from a French expert group: inflammation and remodelling mechanisms]. Rev Mal Respir (2010) 1.40

[Acute tubulo-interstitial nephropathy with uveitis: apropos of case]. Acta Clin Belg (1996) 1.39

A positive response to infliximab in Crohn disease: association with a higher systemic inflammation before treatment but not with -308 TNF gene polymorphism. Scand J Gastroenterol (2002) 1.38

[18FDG-PET applications in thoracic oncology]. Rev Mal Respir (2001) 1.38

Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation. Eur Respir J Suppl (2002) 1.36

MMP-2- and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease. Int Arch Allergy Immunol (2000) 1.33

"Real-life" effectiveness of omalizumab in patients with severe persistent allergic asthma: The PERSIST study. Respir Med (2009) 1.32

Risk of Parkinson's disease among first-degree relatives: A community-based study. Neurology (1996) 1.30

Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease. Clin Exp Immunol (2000) 1.30

Distribution of metals in human lung: analysis by particle induced x-ray emission. Arch Environ Health (1982) 1.26

Management of COPD according to guidelines. A national survey among Belgian physicians. Monaldi Arch Chest Dis (2003) 1.26

Transpedicular screw placement: image-guided versus lateral-view fluoroscopy: in vitro simulation. Spine (Phila Pa 1976) (2001) 1.25

Tumor necrosis factor alpha decreases, and interleukin-10 increases, the sensitivity of human monocytes to dexamethasone: potential regulation of the glucocorticoid receptor. J Clin Endocrinol Metab (1999) 1.25

Traumatic separation of the distal femoral epiphyseal cartilage plate. J Bone Joint Surg Am (1974) 1.25

A long-term, open-label trial of the safety and efficacy of etanercept (Enbrel) in patients with rheumatoid arthritis not treated with other disease-modifying antirheumatic drugs. Ann Rheum Dis (2006) 1.24

Fusion of the lumbar and sacral spine by internal fixation with screw plates. Clin Orthop Relat Res (1986) 1.20

Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naïve patients with ulcerative colitis. J Crohns Colitis (2011) 1.18

The efficacy and safety of a third anti-TNF monoclonal antibody in Crohn's disease after failure of two other anti-TNF antibodies. Aliment Pharmacol Ther (2010) 1.18

Intraventricular cavernomas: three cases and review of the literature. Neurosurgery (1999) 1.16

Effects of ciclesonide and fluticasone on cortisol secretion in patients with persistent asthma. Eur Respir J (2009) 1.12

Clinical applications of assessment of airway inflammation using induced sputum. Eur Respir J Suppl (2002) 1.10

Dyspeptic symptoms in the general population: a factor and cluster analysis of symptom groupings. Neurogastroenterol Motil (2009) 1.07

WHO Collaborating Centre consensus meeting on anti-cytokine therapy in rheumatoid arthritis. Rheumatology (Oxford) (2001) 1.06

Production of tumour necrosis factor-alpha, interferon-gamma and interleukin-2 by peripheral blood mononuclear cells of subjects suffering from rheumatoid arthritis. Scand J Rheumatol (1988) 1.06

Commentary: predicting complicated Crohn's disease and surgery--phenotypes, genetics, serology and psychological characteristics of a population-based cohort. Aliment Pharmacol Ther (2013) 1.06

Anti-alpha-galactosyl antibodies and immune complexes in children with Henoch-Schönlein purpura or IgA nephropathy. Kidney Int (1987) 1.05

Acute lower gastrointestinal bleeding in Crohn's disease: characteristics of a unique series of 34 patients. Belgian IBD Research Group. Am J Gastroenterol (1999) 1.04

Serological markers for prediction of response to anti-tumor necrosis factor treatment in Crohn's disease. Am J Gastroenterol (2002) 1.03

Video capsule endoscopy in small-bowel malignancy: a multicenter Belgian study. Endoscopy (2006) 1.02

Serum calprotectin as a biomarker for Crohn's disease. J Crohns Colitis (2013) 1.02

Effects of chondroitin sulfate and interleukin-1 beta on human articular chondrocytes cultivated in clusters. Osteoarthritis Cartilage (1998) 1.01

Value of FDG-PET in detecting residual or recurrent nonsmall cell lung cancer. Eur Respir J (1999) 1.00

Local and systemic cellular inflammation and cytokine release in chronic obstructive pulmonary disease. Cytokine (2011) 1.00

[Unstable fractures of the spine. III.Instability. A. Theories concerning instability]. Rev Chir Orthop Reparatrice Appar Mot (1978) 0.99

Matrix metalloproteinases and TIMP-1 production by peripheral blood granulocytes from COPD patients and asthmatics. Allergy (2001) 0.99

Pathogenic role of matrix metalloproteases and their inhibitors in asthma and chronic obstructive pulmonary disease and therapeutic relevance of matrix metalloproteases inhibitors. Cell Mol Biol (Noisy-le-grand) (2003) 0.98

Increased frequency of bronchial hyperresponsiveness in patients with inflammatory bowel disease. Allergy (1995) 0.98

Spinal stability as defined by the three-column spine concept. Anat Clin (1985) 0.98

Dentition and dentigerous bones in juveniles and adults of Polypterus senegalus (Cladistia, Actinopterygii). Ann Anat (1998) 0.97

Angiotensin II-induced leukocyte adhesion on human coronary endothelial cells is mediated by E-selectin. Circ Res (1997) 0.97

The efficacy of shortening the dosing interval to once every six weeks in Crohn's patients losing response to maintenance dose of infliximab. Aliment Pharmacol Ther (2010) 0.97

Profile of soluble cytokine receptors in Crohn's disease. Gut (2005) 0.97

Assessment of long-term safety and efficacy of etanercept in a 5-year extension study in patients with rheumatoid arthritis. Clin Exp Rheumatol (2011) 0.95

Nebulised salbutamol administered during sputum induction improves bronchoprotection in patients with asthma. Thorax (2004) 0.95

Quality of life of inoperable non-small cell lung carcinoma. A randomized phase II clinical study comparing radiotherapy alone and combined radio-chemotherapy. Radiother Oncol (1987) 0.95

Measurement of proteoglycans, elastase, collagenase and protein in synovial fluid in inflammatory and degenerative arthropathies. Clin Rheumatol (1985) 0.95

Environmental risk factors for Parkinson's disease in an urban multiethnic community. Neurology (1998) 0.94

Is the neutrophil a worthy target in severe asthma and chronic obstructive pulmonary disease? Clin Exp Allergy (2006) 0.94

Healthcare consumption and direct costs of rheumatoid arthritis in Belgium. Clin Rheumatol (2005) 0.92

Evidence of mast-cell activation in a subset of patients with eosinophilic chronic obstructive pulmonary disease. Eur Respir J (2002) 0.92

Bronchial responsiveness in active steelworkers. Eur Respir J (1998) 0.92

Effects of dexamethasone on the profile of cytokine secretion in human whole blood cell cultures. Regul Pept (1998) 0.91

Induced sputum: comparison between isotonic and hypertonic saline solution inhalation in patients with asthma. Chest (2001) 0.91

IFN-γ and TNF-α potentiate prostaglandin D2-induced human eosinophil chemotaxis through up-regulation of CRTH2 surface receptor. Int Immunopharmacol (2011) 0.90

The development of the tooth pattern and dentigerous bones in Polypterus senegalus (Cladistia, Actinopterygii). Ann Anat (2001) 0.90

Elevated anti-alpha-galactosyl antibody titres. A marker of progression in autoimmune thyroid disorders and in endocrine ophthalmopathy? Acta Endocrinol (Copenh) (1987) 0.90

EULAR report on the use of ultrasonography in painful knee osteoarthritis. Part 2: exploring decision rules for clinical utility. Ann Rheum Dis (2005) 0.90

Possible pathogenic role of IgE in Henoch-Schönlein purpura. Pediatr Nephrol (1994) 0.89

Clinical pattern of corticosteroid dependent Crohn's disease. Eur J Gastroenterol Hepatol (1998) 0.88

Efficiency of informational transfer in regular and complex networks. Phys Rev E Stat Nonlin Soft Matter Phys (2005) 0.88

Increased TGFbeta1 plasma level in patients with lung cancer: potential mechanisms. Eur J Clin Invest (2002) 0.87

Lack of association between adult asthma and the tumour necrosis factor alpha-308 polymorphism gene. Eur Respir J (2000) 0.87

Osteonecrosis in inflammatory bowel diseases: a review of the literature. Acta Gastroenterol Belg (2009) 0.87

The triple neurokinin-receptor antagonist CS-003 inhibits neurokinin A-induced bronchoconstriction in patients with asthma. Pulm Pharmacol Ther (2005) 0.87